169 related articles for article (PubMed ID: 31886306)
1. Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.
Zhang C; Pang G; Ma C; Wu J; Wang P; Wang K
J Immunol Res; 2019; 2019():6263249. PubMed ID: 31886306
[TBL] [Abstract][Full Text] [Related]
2. A prediction model for N2 disease in T1 non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
[TBL] [Abstract][Full Text] [Related]
3. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
4. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
5. [A clinical prediction model for N2 lymph node metastasis in clinical stage I non-small cell lung cancer].
Chen KZ; Yang F; Wang X; Jiang GC; Li JF; Wang J
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):295-301. PubMed ID: 25882948
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Clin Lung Cancer; 2021 Mar; 22(2):120-126.e3. PubMed ID: 33485802
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
8. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
9. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
10. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract][Full Text] [Related]
11. A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer.
Zang RC; Qiu B; Gao SG; He J
Chin Med J (Engl); 2017 Feb; 130(4):398-403. PubMed ID: 28218211
[TBL] [Abstract][Full Text] [Related]
12. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.
Chen B; Xia W; Wang Z; Zhao H; Li X; Liu L; Liu Y; Hu J; Fu X; Li Y; Xu Y; Liu D; Yang H; Xu L; Jiang F
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2771-2777. PubMed ID: 31428933
[TBL] [Abstract][Full Text] [Related]
13. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer.
Chen K; Yang F; Jiang G; Li J; Wang J
Ann Thorac Surg; 2013 Nov; 96(5):1761-8. PubMed ID: 23998401
[TBL] [Abstract][Full Text] [Related]
15. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
[TBL] [Abstract][Full Text] [Related]
16. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
[TBL] [Abstract][Full Text] [Related]
17. Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.
Fukui T; Kato K; Okasaka T; Kawaguchi K; Fukumoto K; Nakamura S; Hakiri S; Ozeki N; Yokoi K
Gen Thorac Cardiovasc Surg; 2017 Nov; 65(11):640-645. PubMed ID: 28866794
[TBL] [Abstract][Full Text] [Related]
18. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
[TBL] [Abstract][Full Text] [Related]
19. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
20. A novel nomogram to predict lymph node metastasis in cT1 non-small-cell lung cancer based on PET/CT and peripheral blood cell parameters.
Wei B; Jin X; Lu G; Zhao T; Xue H; Zhang Y
BMC Pulm Med; 2023 Jan; 23(1):44. PubMed ID: 36717907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]